Last updated: April 4, 2025
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Overall Status: Active - Recruiting
Phase
1
Condition
Cerebral Palsy
Treatment
AlloRx
Clinical Study ID
NCT05018819
SC-11-ATG-11-02
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of Cerebral Palsy
Exclusion
Exclusion Criteria:
Active infection
Active cancer
Chronic multisystem organ failure
Pregnancy
Clinically significant Abnormalities on pre-treatment laboratory evaluation
Medical condition that would (based on the opinion of the investigator) compromisepatient's safety
Previous organ transplant
Seizure disorder
Hypersensitivity to sulfur
Study Design
Total Participants: 15
Treatment Group(s): 1
Primary Treatment: AlloRx
Phase: 1
Study Start date:
February 01, 2022
Estimated Completion Date:
November 30, 2027
Study Description
Connect with a study center
Medical Surgical Associates Center
St. John's,
Antigua and BarbudaActive - Recruiting
Center for Investigation in Tissue Engineering and Cellular Therapy
Buenos Aires,
ArgentinaSite Not Available
Athens Beverly Hills Medical Group
Glyfáda, Athens 16675
GreeceActive - Recruiting
Medyca Bosques
San Pedro Garza García, N.L
MexicoSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.